These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19127431)

  • 41. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis.
    Bisson GP; Bastos M; Campbell JR; Bang D; Brust JC; Isaakidis P; Lange C; Menzies D; Migliori GB; Pape JW; Palmero D; Baghaei P; Tabarsi P; Viiklepp P; Vilbrun S; Walsh J; Marks SM
    Lancet; 2020 Aug; 396(10248):402-411. PubMed ID: 32771107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors associated with multidrug-resistant tuberculosis: comparison of patients born inside and outside of the Czech Republic.
    Bartu V; Kopecka E; Havelkova M
    J Int Med Res; 2010; 38(3):1156-63. PubMed ID: 20819455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis.
    Pablos-Méndez A; Sterling TR; Frieden TR
    JAMA; 1996 Oct; 276(15):1223-8. PubMed ID: 8849749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study.
    Soeroto AY; Pratiwi C; Santoso P; Lestari BW
    PLoS One; 2021; 16(2):e0246284. PubMed ID: 33556094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study.
    Thu MK; Kumar AMV; Soe KT; Saw S; Thein S; Mynit Z; Maung HMW; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):410-417. PubMed ID: 29351672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and validation of a computer-based algorithm to identify foreign-born patients with HIV infection from the electronic medical record.
    Levison J; Triant V; Losina E; Keefe K; Freedberg K; Regan S
    Appl Clin Inform; 2014; 5(2):557-70. PubMed ID: 25024769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculosis reaches new milestones, good and bad.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 Dec; 15(12):1361. PubMed ID: 26607114
    [No Abstract]   [Full Text] [Related]  

  • 50. Impact of language barriers on complications and mortality among immigrants with diabetes: a population-based cohort study.
    Okrainec K; Booth GL; Hollands S; Bell CM
    Diabetes Care; 2015 Feb; 38(2):189-96. PubMed ID: 25028526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to poor treatment outcome and its predictors among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara region, Ethiopia: retrospective cohort study.
    Ketema DB; Muchie KF; Andargie AA
    BMC Public Health; 2019 Nov; 19(1):1481. PubMed ID: 31703667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evolution of endemic tuberculosis in Olt county, Romania, between 1990 and 2008].
    Golli AL; Didilescu C; Niţu MF; Eparu I
    Pneumologia; 2011; 60(3):132-7. PubMed ID: 22097434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug-resistant tuberculosis in Alberta and British Columbia, 1989 to 1998.
    Hersi A; Elwood K; Cowie R; Kunimoto D; Long R
    Can Respir J; 1999; 6(2):155-60. PubMed ID: 10322098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors influencing the length of hospital stay during the intensive phase of multidrug-resistant tuberculosis treatment at Amhara regional state hospitals, Ethiopia: a retrospective follow up study.
    Tamirat KS; Andargie G; Babel YA
    BMC Public Health; 2020 Aug; 20(1):1217. PubMed ID: 32770982
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].
    Wang JJ; Zhou ML; Chen C; Wu G; Zuo YP; Ren X; Chen Z; Wang WH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1409-1413. PubMed ID: 31838813
    [No Abstract]   [Full Text] [Related]  

  • 58. Mortality of hospitalized tuberculosis patients in Israel.
    Chemtob D
    Isr Med Assoc J; 2008 Mar; 10(3):245; author reply 245. PubMed ID: 18494246
    [No Abstract]   [Full Text] [Related]  

  • 59. Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
    Zhao Y; Fox T; Manning K; Stewart A; Tiffin N; Khomo N; Leslie J; Boulle A; Mudaly V; Kock Y; Meintjes G; Wasserman S
    Clin Infect Dis; 2019 Apr; 68(9):1522-1529. PubMed ID: 30165431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Renaissance of tuberculosis?].
    Meyer FJ; Konietzko N
    Internist (Berl); 1995 Dec; 36(12):1162-73. PubMed ID: 8567222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.